“…Initial studies reported CMV inclusion bodies in colectomy specimens with fulminant or steroid-refractory UC [8,15,16]. In addition, treatment with steroids [17], cyclosporine [18], anti-TNF agents [19], and leukapharesis [20] has been associated with an increased risk of CMV infection. However, other studies have challenged the pathogenicity of CMV in active IBD by demonstrating a lack of correlation of CMV and clinical severity of IBD [21].…”